Skip to main content
. 2015 Mar 7;21(9):2746–2753. doi: 10.3748/wjg.v21.i9.2746

Figure 2.

Figure 2

Comparison of cumulative probability of complete virological response in patients undergoing therapy with tenofovir disoproxil fumarate or lamivudine plus adefovir. Tenofovir disoproxil fumarate (TDF) alone is represented by the medium weight line; lamivudine plus adefovir (LAM plus ADV) combination is shown by the dotted line; and both arms by the dashed line (P < 0.001). Baseline serum HBV DNA level showed no difference (P = 0. 639). LAM: Lamivudine; ADV: Adefovir; HBV: Hepatitis B virus.